Skip to search formSkip to main contentSkip to account menu

Epithelial ovarian cancer

Known as: carcinoma, ovarian epithelial, Ovarian epithelial cancer, epithelial ovarian carcinoma 
A malignant neoplasm originating from the surface ovarian epithelium. It accounts for the greatest number of deaths from malignancies of the female… 
National Institutes of Health

Related topics

Related topics

50 relations
ADAM11 protein, humanAKT2 protein, humanAKT2 wt AlleleBRCA1 Associated RING Domain 1 Protein

Narrower (1)

Malignant Brenner Tumor

Broader (4)

NeoplasmsNeoplasms, Glandular and EpithelialOvarian Carcinomaovarian neoplasm

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2018
Highly Cited
2018
Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
J. A. Ledermann1, F. A. Raja1, C. Fotopoulou2, A. Gonzalez-Martin3, N. Colombo4 & C. Sessa5, on behalf of the ESMO Guidelines… 
Review
2012
Review
2012
Therapeutic strategies in epithelial ovarian cancer
Ovarian cancer is the most lethal gynecologic malignancy. It appears that the vast majority of what seem to be primary epithelial… 
Highly Cited
2008
Highly Cited
2008
Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer
MicroRNAs (miRNAs) are an abundant class of small noncoding RNAs that function as negative gene regulators. miRNA deregulation is… 
Review
2008
Review
2008
Early events in the pathogenesis of epithelial ovarian cancer.
Ovarian carcinogenesis, as in most cancers, involves multiple genetic alterations. A great deal has been learned about proteins… 
Highly Cited
2008
Highly Cited
2008
miR-210 links hypoxia with cell cycle regulation and is deleted in human epithelial ovarian cancer
Tumor growth results in hypoxia. Understanding the mechanisms of gene expression reprogramming under hypoxia may provide… 
Highly Cited
2005
Highly Cited
2005
Stem and progenitor-like cells contribute to the aggressive behavior of human epithelial ovarian cancer.
The cellular mechanisms underlying the increasing aggressiveness associated with ovarian cancer progression are poorly understood… 
Highly Cited
2005
Highly Cited
2005
Detection of epithelial ovarian cancer using 1H‐NMR‐based metabonomics
Currently available serum biomarkers are insufficiently reliable to distinguish patients with epithelial ovarian cancer (EOC… 
Highly Cited
2000
Highly Cited
2000
Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results.
BACKGROUND A randomized trial conducted by the Gynecologic Oncology Group (GOG, study #111) in the United States showed a better… 
Highly Cited
2000
Highly Cited
2000
High levels of stromal hyaluronan predict poor disease outcome in epithelial ovarian cancer.
Several malignant tumors accumulate hyaluronan, a matrix component suggested to promote cancer cell migration and growth. To… 
Highly Cited
1998
Highly Cited
1998
Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: a prospective study.
OBJECTIVE Despite correlation between the completeness of surgical cytoreduction and survival for patients with advanced ovarian… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)